| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $14.5M | +90.4% |
| Cost of Revenue | $5.9M | +0.4% |
| Gross Profit | $8.7M | +381.2% |
| R&D Expense | $162K | +1076.3% |
| Operating Income | $16.3M | +253.2% |
| Interest Expense | $98K | — |
| Pre-tax Income | $2.4M | +120.4% |
| Income Tax | $2.4M | +195.7% |
| Net Income | $459K | +104.1% |
| EPS (Basic) | $0.01 | +104.0% |
| EPS (Diluted) | $0.01 | +104.0% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.2M | +263.8% |
| Short-term Investments | $56K | -0.9% |
| Accounts Receivable | $1.1M | +26.8% |
| Current Assets | $12.7M | +238.6% |
| Total Assets | $28.5M | -6.9% |
| Current Liabilities | $20.9M | +34.8% |
| Total Liabilities | $22.5M | +42.6% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.3M | -329.3% |
| Capital Expenditures | $20K | +1795.7% |
| Investing Cash Flow | -$31.3M | +27.0% |
| Financing Cash Flow | $52.0M | +79.9% |
| Free Cash Flow | -$18.4M | -329.6% |
| Stockholders' Equity |
| $5.3M |
| +719.0% |